Market Research Report
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
|Published by||BioSeeker Group AB||Product code||239835|
|Published||Content info||5472 Pages
Delivery time: 1-2 business days
|Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors|
|Published: June 12, 2013||Content info: 5472 Pages||
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.